Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypomagnesemia × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11166 Neoplasms 8937 Carcinoma, Non-Small-Cell Lung 5785 Prostatic Neoplasms 5363 Colorectal Neoplasms 5023 Lung Neoplasms 4290 Multiple Myeloma 3042 Pancreatic Neoplasms 3038 Neoplasm Metastasis 2992 Leukemia, Myeloid, Acute 2975 Carcinoma, Hepatocellular 2774 Ovarian Neoplasms 2705 Melanoma 2677 Stomach Neoplasms 2604 Lymphoma 2542 Head and Neck Neoplasms 2202 Recurrence 2159 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2107 Leukemia 2030 Brain Neoplasms 1997 Colonic Neoplasms 1955 Lymphoma, Non-Hodgkin 1916 Rectal Neoplasms 1870 Uterine Cervical Neoplasms 1835 Glioblastoma 1721 Leukemia, Lymphocytic, Chronic, B-Cell 1689 Carcinoma, Renal Cell 1625 Squamous Cell Carcinoma of Head and Neck 1580 Lymphoma, Follicular 1546 Esophageal Neoplasms 1527

Interventions

magnesium citrate 1 Magnesium Oxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02690012 2019-09-06

OTT 15-03

Ottawa Hospital Research Institute

Phase NA Completed

Hypomagnesemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡